in this issue
Regions :: North America
Novozymes acquires Allopartis Biotechnologies
October 11, 2013 | Natasha Alperowicz
Novozymes has acquired Allopartis Biotechnologies (San Francisco) from CalCEF Clean Energy Angel Fund I (San Francisco) for an undisclosed sum. Allopartis, founded in 2008, specializes in screening enzymes for industrial use. CalCEF Clean Energy Angel Fund I is a seed and early-stage venture capital fund focusing entirely on emerging, transformative technology in the clean energy markets. It made its first investment in Allopartis in September 2008, along with XSeed Capital, the company says. “Novozymes looks forward to integrate and...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee